| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sequence Analysis, RNA | 10 | 2024 | 155 | 2.390 |
Why?
|
| Transcriptome | 10 | 2024 | 329 | 1.530 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2020 | 100 | 1.480 |
Why?
|
| Evolution, Molecular | 12 | 2018 | 291 | 1.410 |
Why?
|
| Genomics | 10 | 2020 | 314 | 1.280 |
Why?
|
| Genome, Human | 8 | 2019 | 218 | 1.130 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2021 | 145 | 1.050 |
Why?
|
| Sequence Analysis, DNA | 15 | 2019 | 397 | 0.970 |
Why?
|
| Promoter Regions, Genetic | 3 | 2020 | 659 | 0.960 |
Why?
|
| Software | 6 | 2020 | 367 | 0.940 |
Why?
|
| Islets of Langerhans | 4 | 2023 | 267 | 0.910 |
Why?
|
| Dendritic Cells | 8 | 2020 | 508 | 0.850 |
Why?
|
| RNA, Long Noncoding | 2 | 2016 | 152 | 0.820 |
Why?
|
| Fragile X Syndrome | 1 | 2022 | 28 | 0.770 |
Why?
|
| Conserved Sequence | 8 | 2018 | 171 | 0.740 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 1538 | 0.720 |
Why?
|
| Gene Expression Profiling | 12 | 2024 | 702 | 0.710 |
Why?
|
| Single-Cell Analysis | 5 | 2024 | 88 | 0.700 |
Why?
|
| Bacteria | 3 | 2020 | 275 | 0.670 |
Why?
|
| Sequence Alignment | 6 | 2016 | 290 | 0.600 |
Why?
|
| Animals | 40 | 2024 | 19649 | 0.590 |
Why?
|
| Mice | 27 | 2024 | 10274 | 0.560 |
Why?
|
| Immunity, Innate | 3 | 2020 | 762 | 0.510 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2019 | 251 | 0.510 |
Why?
|
| Chromatin | 8 | 2021 | 594 | 0.490 |
Why?
|
| RNA, Untranslated | 6 | 2017 | 101 | 0.460 |
Why?
|
| Genetic Variation | 5 | 2018 | 364 | 0.430 |
Why?
|
| Genome | 6 | 2018 | 253 | 0.410 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 73 | 0.390 |
Why?
|
| Skin | 2 | 2024 | 356 | 0.380 |
Why?
|
| Epigenesis, Genetic | 6 | 2021 | 351 | 0.370 |
Why?
|
| Herpesvirus 4, Human | 3 | 2018 | 181 | 0.350 |
Why?
|
| Base Sequence | 7 | 2017 | 1311 | 0.330 |
Why?
|
| Mammals | 4 | 2022 | 204 | 0.320 |
Why?
|
| Vitiligo | 2 | 2021 | 120 | 0.310 |
Why?
|
| DNA | 5 | 2021 | 792 | 0.300 |
Why?
|
| RNA | 5 | 2023 | 403 | 0.290 |
Why?
|
| CRISPR-Cas Systems | 3 | 2017 | 327 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 7 | 2020 | 3193 | 0.270 |
Why?
|
| Gene Library | 3 | 2016 | 99 | 0.270 |
Why?
|
| Computational Biology | 7 | 2018 | 327 | 0.260 |
Why?
|
| Transcription Factors | 7 | 2020 | 1457 | 0.260 |
Why?
|
| Humans | 41 | 2024 | 59471 | 0.260 |
Why?
|
| Transcription, Genetic | 8 | 2014 | 847 | 0.250 |
Why?
|
| Algorithms | 2 | 2020 | 992 | 0.250 |
Why?
|
| RNA, Fungal | 2 | 2017 | 36 | 0.250 |
Why?
|
| Viral Matrix Proteins | 2 | 2016 | 51 | 0.240 |
Why?
|
| Rats | 4 | 2023 | 1914 | 0.240 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2018 | 90 | 0.240 |
Why?
|
| Dermatitis, Irritant | 1 | 2024 | 4 | 0.240 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2024 | 13 | 0.240 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2024 | 22 | 0.240 |
Why?
|
| CRISPR-Associated Proteins | 2 | 2015 | 31 | 0.230 |
Why?
|
| Toll-Like Receptors | 3 | 2018 | 434 | 0.230 |
Why?
|
| Gene Regulatory Networks | 3 | 2021 | 139 | 0.220 |
Why?
|
| Molecular Sequence Annotation | 4 | 2017 | 59 | 0.220 |
Why?
|
| Spermatozoa | 2 | 2015 | 251 | 0.220 |
Why?
|
| Cells, Cultured | 6 | 2021 | 2099 | 0.220 |
Why?
|
| Epididymis | 2 | 2020 | 27 | 0.210 |
Why?
|
| Chromosome Mapping | 3 | 2021 | 293 | 0.200 |
Why?
|
| DNA-Binding Proteins | 3 | 2019 | 1131 | 0.200 |
Why?
|
| Prediabetic State | 1 | 2023 | 52 | 0.200 |
Why?
|
| Pluripotent Stem Cells | 2 | 2014 | 67 | 0.200 |
Why?
|
| Olfactory Bulb | 1 | 2022 | 15 | 0.200 |
Why?
|
| Fibroblasts | 2 | 2022 | 370 | 0.200 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2022 | 13 | 0.200 |
Why?
|
| RNA, Messenger | 5 | 2017 | 1468 | 0.190 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2022 | 37 | 0.190 |
Why?
|
| HIV-1 | 2 | 2020 | 705 | 0.190 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 2021 | 6 | 0.190 |
Why?
|
| Receptors, CCR5 | 1 | 2021 | 57 | 0.190 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2022 | 133 | 0.180 |
Why?
|
| Endothelial Cells | 1 | 2022 | 176 | 0.180 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 113 | 0.180 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2021 | 57 | 0.180 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2017 | 530 | 0.180 |
Why?
|
| Stochastic Processes | 1 | 2020 | 26 | 0.180 |
Why?
|
| Vas Deferens | 1 | 2020 | 4 | 0.180 |
Why?
|
| Synapses | 1 | 2022 | 178 | 0.180 |
Why?
|
| Lung | 2 | 2022 | 833 | 0.180 |
Why?
|
| Nasal Mucosa | 1 | 2020 | 16 | 0.180 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2020 | 7 | 0.180 |
Why?
|
| Goblet Cells | 1 | 2020 | 8 | 0.180 |
Why?
|
| Female | 16 | 2024 | 30895 | 0.170 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2020 | 8 | 0.170 |
Why?
|
| Enterocytes | 1 | 2020 | 25 | 0.170 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 39 | 0.170 |
Why?
|
| Endocrine Cells | 1 | 2019 | 10 | 0.170 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 279 | 0.170 |
Why?
|
| Viruses | 2 | 2011 | 79 | 0.170 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 2019 | 4 | 0.170 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 196 | 0.170 |
Why?
|
| Adipocytes, Beige | 1 | 2019 | 15 | 0.160 |
Why?
|
| Tumor Escape | 1 | 2019 | 16 | 0.160 |
Why?
|
| Adiponectin | 1 | 2019 | 33 | 0.160 |
Why?
|
| Linear Models | 1 | 2020 | 422 | 0.160 |
Why?
|
| Exons | 4 | 2014 | 193 | 0.160 |
Why?
|
| B7-H1 Antigen | 1 | 2019 | 53 | 0.160 |
Why?
|
| Leptin | 1 | 2019 | 78 | 0.160 |
Why?
|
| Lymphocytes | 1 | 2020 | 193 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2024 | 646 | 0.160 |
Why?
|
| Male | 15 | 2024 | 27561 | 0.150 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 214 | 0.150 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2019 | 130 | 0.150 |
Why?
|
| Interferon Type I | 1 | 2020 | 167 | 0.150 |
Why?
|
| DNA, Viral | 2 | 2016 | 228 | 0.150 |
Why?
|
| Thermogenesis | 1 | 2019 | 108 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2009 | 6 | 0.150 |
Why?
|
| tRNA Methyltransferases | 1 | 2017 | 8 | 0.150 |
Why?
|
| Insulin-Secreting Cells | 2 | 2019 | 177 | 0.150 |
Why?
|
| Data Interpretation, Statistical | 1 | 2019 | 197 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 2 | 2021 | 201 | 0.150 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 276 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2023 | 602 | 0.140 |
Why?
|
| Histones | 3 | 2021 | 463 | 0.140 |
Why?
|
| Antigen Presentation | 1 | 2019 | 228 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2021 | 2887 | 0.140 |
Why?
|
| Down-Regulation | 3 | 2019 | 305 | 0.140 |
Why?
|
| Cell Differentiation | 2 | 2014 | 1294 | 0.140 |
Why?
|
| Haplotypes | 5 | 2010 | 116 | 0.140 |
Why?
|
| Viral Load | 2 | 2016 | 229 | 0.140 |
Why?
|
| Deoxyribonucleases | 1 | 2017 | 30 | 0.140 |
Why?
|
| Mice, Knockout | 1 | 2022 | 1988 | 0.140 |
Why?
|
| Genome, Viral | 1 | 2018 | 120 | 0.140 |
Why?
|
| Embryonic Stem Cells | 5 | 2021 | 150 | 0.140 |
Why?
|
| Molecular Sequence Data | 8 | 2014 | 1975 | 0.140 |
Why?
|
| RNA, Transfer | 1 | 2017 | 77 | 0.140 |
Why?
|
| Cell Nucleus | 2 | 2018 | 603 | 0.140 |
Why?
|
| RNA-Binding Proteins | 3 | 2013 | 384 | 0.140 |
Why?
|
| Chromosomes | 1 | 2018 | 133 | 0.140 |
Why?
|
| Databases, Genetic | 1 | 2017 | 83 | 0.140 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 964 | 0.140 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2017 | 123 | 0.140 |
Why?
|
| Membrane Glycoproteins | 2 | 2016 | 667 | 0.130 |
Why?
|
| Statistics as Topic | 1 | 2017 | 147 | 0.130 |
Why?
|
| Infectious Mononucleosis | 1 | 2016 | 35 | 0.130 |
Why?
|
| Transcriptional Activation | 2 | 2015 | 189 | 0.130 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2016 | 25 | 0.130 |
Why?
|
| Neurons | 1 | 2022 | 860 | 0.130 |
Why?
|
| Microfluidics | 1 | 2016 | 22 | 0.130 |
Why?
|
| Ebolavirus | 1 | 2016 | 35 | 0.130 |
Why?
|
| Organ Specificity | 2 | 2014 | 179 | 0.130 |
Why?
|
| RNA, Transfer, Gly | 1 | 2015 | 5 | 0.130 |
Why?
|
| DNA, Ribosomal | 1 | 2015 | 29 | 0.130 |
Why?
|
| DNA, Intergenic | 3 | 2010 | 23 | 0.130 |
Why?
|
| Sperm Maturation | 1 | 2015 | 9 | 0.130 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2017 | 419 | 0.130 |
Why?
|
| Cytokines | 1 | 2020 | 905 | 0.130 |
Why?
|
| Viral Envelope Proteins | 1 | 2016 | 108 | 0.130 |
Why?
|
| Ribosomes | 1 | 2017 | 153 | 0.130 |
Why?
|
| Thermus thermophilus | 1 | 1995 | 19 | 0.120 |
Why?
|
| Somatostatin-Secreting Cells | 1 | 2015 | 8 | 0.120 |
Why?
|
| Fertilization | 1 | 2015 | 82 | 0.120 |
Why?
|
| Gene Targeting | 1 | 2015 | 82 | 0.120 |
Why?
|
| Models, Biological | 1 | 2020 | 1141 | 0.120 |
Why?
|
| Ribosomal Proteins | 1 | 1995 | 41 | 0.120 |
Why?
|
| HIV Infections | 3 | 2020 | 920 | 0.120 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2015 | 26 | 0.120 |
Why?
|
| Histone Demethylases | 1 | 2015 | 11 | 0.120 |
Why?
|
| Caspase 9 | 1 | 2015 | 22 | 0.120 |
Why?
|
| Genes, Bacterial | 1 | 1995 | 117 | 0.120 |
Why?
|
| Antibodies, Neutralizing | 1 | 2016 | 191 | 0.120 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2014 | 21 | 0.120 |
Why?
|
| Fetus | 1 | 2015 | 97 | 0.120 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 452 | 0.120 |
Why?
|
| B-Lymphocytes | 2 | 2016 | 550 | 0.120 |
Why?
|
| Interferon Regulatory Factors | 1 | 2014 | 39 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 305 | 0.120 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2015 | 85 | 0.120 |
Why?
|
| Phylogeny | 5 | 2018 | 332 | 0.120 |
Why?
|
| Cluster Analysis | 4 | 2021 | 251 | 0.120 |
Why?
|
| PPAR alpha | 1 | 2014 | 28 | 0.120 |
Why?
|
| Proviruses | 1 | 2014 | 23 | 0.110 |
Why?
|
| Oropharynx | 1 | 2014 | 12 | 0.110 |
Why?
|
| Fibroblast Growth Factors | 1 | 2014 | 63 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2015 | 630 | 0.110 |
Why?
|
| Anti-Retroviral Agents | 1 | 2014 | 73 | 0.110 |
Why?
|
| Inflammation | 3 | 2023 | 1097 | 0.110 |
Why?
|
| HEK293 Cells | 4 | 2019 | 575 | 0.110 |
Why?
|
| Secondary Prevention | 1 | 2014 | 153 | 0.110 |
Why?
|
| Endonucleases | 1 | 2014 | 81 | 0.110 |
Why?
|
| Cell Line | 3 | 2020 | 2013 | 0.110 |
Why?
|
| Cattle | 1 | 2014 | 304 | 0.110 |
Why?
|
| Selection, Genetic | 2 | 2011 | 69 | 0.110 |
Why?
|
| Drosophila melanogaster | 1 | 2017 | 480 | 0.110 |
Why?
|
| Synteny | 6 | 2009 | 24 | 0.100 |
Why?
|
| Escherichia coli Proteins | 1 | 1995 | 260 | 0.100 |
Why?
|
| RNA Stability | 1 | 2013 | 93 | 0.100 |
Why?
|
| RNA Polymerase II | 3 | 2021 | 71 | 0.100 |
Why?
|
| Models, Genetic | 2 | 2010 | 253 | 0.100 |
Why?
|
| Bacterial Proteins | 2 | 2015 | 749 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 255 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2008 | 453 | 0.090 |
Why?
|
| Cellular Reprogramming | 1 | 2010 | 32 | 0.090 |
Why?
|
| Embryonic Development | 1 | 2011 | 136 | 0.090 |
Why?
|
| Liver | 1 | 2014 | 784 | 0.080 |
Why?
|
| Horses | 1 | 2009 | 49 | 0.080 |
Why?
|
| Chromosomes, Mammalian | 1 | 2009 | 34 | 0.080 |
Why?
|
| Open Reading Frames | 3 | 2018 | 82 | 0.080 |
Why?
|
| Gene Duplication | 2 | 2006 | 32 | 0.080 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 322 | 0.080 |
Why?
|
| Neoplasms | 1 | 2019 | 1244 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2010 | 134 | 0.080 |
Why?
|
| Melanoma | 1 | 2013 | 334 | 0.080 |
Why?
|
| Zebrafish | 1 | 2011 | 323 | 0.080 |
Why?
|
| Epigenomics | 2 | 2021 | 54 | 0.080 |
Why?
|
| Dogs | 2 | 2009 | 310 | 0.080 |
Why?
|
| Adult | 6 | 2024 | 15771 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 299 | 0.080 |
Why?
|
| Superoxide Dismutase | 1 | 2009 | 213 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2016 | 1578 | 0.070 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 404 | 0.070 |
Why?
|
| Opossums | 1 | 2007 | 3 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2009 | 336 | 0.070 |
Why?
|
| Retroelements | 2 | 2017 | 39 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2006 | 23 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2006 | 22 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2005 | 6 | 0.060 |
Why?
|
| Genotype | 2 | 2018 | 637 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2020 | 363 | 0.060 |
Why?
|
| Young Adult | 4 | 2019 | 4321 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 1552 | 0.060 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2024 | 8 | 0.060 |
Why?
|
| Drug Eruptions | 1 | 2024 | 14 | 0.060 |
Why?
|
| Interleukin-4 | 1 | 2024 | 141 | 0.060 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2009 | 476 | 0.060 |
Why?
|
| Macaca mulatta | 2 | 2020 | 247 | 0.060 |
Why?
|
| Cytoplasm | 2 | 2016 | 273 | 0.060 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 165 | 0.050 |
Why?
|
| Polymorphism, Genetic | 3 | 2010 | 194 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 1094 | 0.050 |
Why?
|
| Rats, Inbred Lew | 1 | 2023 | 110 | 0.050 |
Why?
|
| Genes | 3 | 2009 | 96 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 693 | 0.050 |
Why?
|
| Middle Aged | 4 | 2024 | 16259 | 0.050 |
Why?
|
| Proteomics | 1 | 2024 | 256 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2024 | 542 | 0.050 |
Why?
|
| Odorants | 1 | 2022 | 17 | 0.050 |
Why?
|
| Feedback, Physiological | 2 | 2014 | 58 | 0.050 |
Why?
|
| Smell | 1 | 2022 | 23 | 0.050 |
Why?
|
| Trachea | 1 | 2022 | 92 | 0.050 |
Why?
|
| NFATC Transcription Factors | 1 | 2021 | 20 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 904 | 0.050 |
Why?
|
| Adolescent | 3 | 2020 | 5917 | 0.050 |
Why?
|
| Histone Code | 1 | 2021 | 25 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2014 | 249 | 0.050 |
Why?
|
| Republic of Korea | 1 | 2021 | 27 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2021 | 36 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2022 | 208 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2011 | 193 | 0.040 |
Why?
|
| Epitopes | 1 | 2021 | 295 | 0.040 |
Why?
|
| Programming Languages | 1 | 2020 | 15 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2022 | 376 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2020 | 82 | 0.040 |
Why?
|
| Genetic Loci | 2 | 2010 | 104 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 63 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2020 | 82 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 71 | 0.040 |
Why?
|
| Biomarkers | 1 | 2024 | 1198 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2015 | 1839 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2021 | 461 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2020 | 130 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 223 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2020 | 472 | 0.040 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2019 | 170 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 739 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 195 | 0.040 |
Why?
|
| Graft Survival | 1 | 2019 | 279 | 0.040 |
Why?
|
| Protein Binding | 2 | 2014 | 1553 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2019 | 100 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 160 | 0.040 |
Why?
|
| Eukaryota | 1 | 2018 | 29 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2019 | 526 | 0.040 |
Why?
|
| Terminal Repeat Sequences | 1 | 2017 | 13 | 0.040 |
Why?
|
| Child | 2 | 2020 | 4308 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2020 | 276 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2020 | 193 | 0.040 |
Why?
|
| Exonucleases | 1 | 2017 | 4 | 0.040 |
Why?
|
| 5' Flanking Region | 1 | 2017 | 9 | 0.040 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2017 | 39 | 0.040 |
Why?
|
| RNA, Ribosomal | 1 | 2017 | 53 | 0.040 |
Why?
|
| 3' Flanking Region | 1 | 2017 | 7 | 0.040 |
Why?
|
| Ribonuclease H | 1 | 2017 | 18 | 0.040 |
Why?
|
| Methylation | 1 | 2017 | 127 | 0.040 |
Why?
|
| Cell Nucleolus | 1 | 2018 | 68 | 0.040 |
Why?
|
| Homeostasis | 1 | 2020 | 342 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 375 | 0.040 |
Why?
|
| Genes, Insect | 1 | 2017 | 89 | 0.030 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 187 | 0.030 |
Why?
|
| Convalescence | 1 | 2016 | 17 | 0.030 |
Why?
|
| Lipopolysaccharides | 2 | 2011 | 645 | 0.030 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 199 | 0.030 |
Why?
|
| Africa, Western | 1 | 2016 | 5 | 0.030 |
Why?
|
| Cheirogaleidae | 1 | 2016 | 6 | 0.030 |
Why?
|
| Base Composition | 2 | 2007 | 27 | 0.030 |
Why?
|
| Time Factors | 2 | 2015 | 3578 | 0.030 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2016 | 21 | 0.030 |
Why?
|
| Callithrix | 1 | 2016 | 19 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2016 | 75 | 0.030 |
Why?
|
| Tuberculosis | 1 | 2020 | 263 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 483 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 840 | 0.030 |
Why?
|
| Short Interspersed Nucleotide Elements | 2 | 2006 | 4 | 0.030 |
Why?
|
| Virulence | 1 | 2016 | 189 | 0.030 |
Why?
|
| Diet, Protein-Restricted | 1 | 2015 | 12 | 0.030 |
Why?
|
| Virion | 1 | 2016 | 116 | 0.030 |
Why?
|
| Mutation | 2 | 2017 | 2445 | 0.030 |
Why?
|
| DNA Cleavage | 1 | 2015 | 18 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 252 | 0.030 |
Why?
|
| Multigene Family | 2 | 2006 | 93 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 384 | 0.030 |
Why?
|
| Insulin | 1 | 2019 | 686 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2016 | 252 | 0.030 |
Why?
|
| Crystallization | 1 | 1995 | 97 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2015 | 95 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 609 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 37 | 0.030 |
Why?
|
| Blastocyst | 1 | 2015 | 76 | 0.030 |
Why?
|
| Testis | 1 | 2015 | 136 | 0.030 |
Why?
|
| Acute Disease | 1 | 2016 | 658 | 0.030 |
Why?
|
| Monocytes | 1 | 2016 | 345 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 385 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 238 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 130 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 324 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2014 | 37 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2015 | 243 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 1995 | 422 | 0.030 |
Why?
|
| SOXF Transcription Factors | 1 | 2014 | 10 | 0.030 |
Why?
|
| Neisseria meningitidis | 1 | 2015 | 104 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2014 | 17 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2014 | 94 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 1150 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2015 | 274 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 674 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1055 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3096 | 0.030 |
Why?
|
| Exoribonucleases | 1 | 2013 | 25 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2016 | 736 | 0.030 |
Why?
|
| Genes, Fungal | 1 | 2013 | 54 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 160 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 237 | 0.030 |
Why?
|
| Semiconductors | 1 | 2013 | 13 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2014 | 298 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 1374 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2017 | 682 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2016 | 709 | 0.020 |
Why?
|
| Disease | 1 | 2011 | 26 | 0.020 |
Why?
|
| Health | 1 | 2011 | 32 | 0.020 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2011 | 91 | 0.020 |
Why?
|
| Interferons | 1 | 2011 | 63 | 0.020 |
Why?
|
| Biotinylation | 1 | 2011 | 38 | 0.020 |
Why?
|
| Diet | 1 | 2015 | 634 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2014 | 404 | 0.020 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2010 | 1 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 118 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1995 | 685 | 0.020 |
Why?
|
| Population Groups | 1 | 2010 | 12 | 0.020 |
Why?
|
| Animals, Domestic | 1 | 2009 | 13 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 1306 | 0.020 |
Why?
|
| Lipopeptides | 1 | 2009 | 17 | 0.020 |
Why?
|
| Centromere | 1 | 2009 | 39 | 0.020 |
Why?
|
| Poly I-C | 1 | 2009 | 74 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2009 | 75 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 619 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2009 | 37 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2009 | 65 | 0.020 |
Why?
|
| Polycomb-Group Proteins | 1 | 2009 | 21 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 1523 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 525 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2009 | 52 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2010 | 96 | 0.020 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2009 | 136 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 2009 | 100 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 807 | 0.020 |
Why?
|
| Haploidy | 1 | 2008 | 10 | 0.020 |
Why?
|
| Diploidy | 1 | 2008 | 11 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 291 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2443 | 0.020 |
Why?
|
| Quality Control | 1 | 2008 | 69 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2354 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2009 | 229 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 1128 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2007 | 56 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 498 | 0.020 |
Why?
|
| Obesity | 1 | 2014 | 1185 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2007 | 127 | 0.020 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2006 | 17 | 0.020 |
Why?
|
| Defensins | 1 | 2006 | 5 | 0.020 |
Why?
|
| Contig Mapping | 1 | 2006 | 4 | 0.020 |
Why?
|
| DNA, Satellite | 1 | 2006 | 14 | 0.020 |
Why?
|
| Hybridization, Genetic | 1 | 2005 | 14 | 0.020 |
Why?
|
| Euchromatin | 1 | 2006 | 16 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2005 | 27 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2005 | 130 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2005 | 37 | 0.020 |
Why?
|
| Dog Diseases | 1 | 2005 | 54 | 0.020 |
Why?
|
| Introns | 1 | 2005 | 106 | 0.020 |
Why?
|
| Apoptosis | 1 | 2010 | 1038 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2007 | 293 | 0.010 |
Why?
|
| Disease Progression | 1 | 2009 | 1046 | 0.010 |
Why?
|
| CpG Islands | 1 | 2005 | 212 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 5174 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 5098 | 0.010 |
Why?
|
| Aged | 1 | 2009 | 13342 | 0.010 |
Why?
|